Cue Health EBITDA Margin 2020-2023 | HLTH

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cue Health (HLTH) over the last 10 years. The current EBITDA margin for Cue Health as of December 31, 2023 is .
Cue Health EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $0.07B $-0.34B -477.46%
2023-09-30 $0.20B $-0.23B -116.08%
2023-06-30 $0.25B $-0.24B -93.65%
2023-03-31 $0.33B $-0.25B -76.97%
2022-12-31 $0.48B $-0.16B -32.44%
2022-09-30 $0.53B $-0.10B -19.62%
2022-06-30 $0.68B $0.05B 7.46%
2022-03-31 $0.73B $0.22B 29.47%
2021-12-31 $0.62B $0.22B 36.08%
2021-06-30 $0.21B $0.09B 41.26%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.023B $0.071B
Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.221B 21.82
Inspire Medical Systems (INSP) United States $6.999B 0.00
IRhythm Technologies (IRTC) United States $3.463B 0.00
Axonics (AXNX) United States $3.394B 0.00
10x Genomics (TXG) United States $3.206B 0.00
Enovis (ENOV) United States $3.022B 22.96
Azenta (AZTA) United States $2.872B 234.09
Olink Holding AB (publ) (OLK) Sweden $2.869B 0.00
Hims & Hers Health (HIMS) United States $2.629B 0.00
Privia Health (PRVA) United States $2.135B 94.68
Schrodinger (SDGR) United States $1.688B 0.00
Omnicell (OMCL) United States $1.246B 30.48
Phreesia (PHR) United States $1.154B 0.00
Definitive Healthcare (DH) United States $0.793B 0.00
Standard BioTools (LAB) United States $0.685B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Talkspace (TALK) United States $0.520B 0.00
Clover Health Investments (CLOV) United States $0.332B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.323B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
American Well (AMWL) United States $0.156B 0.00
P3 Health Partners (PIII) United States $0.152B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.136B 0.00
MSP Recovery (LIFW) United States $0.131B 0.00
Outset Medical (OM) United States $0.123B 0.00
TruBridge (TBRG) United States $0.115B 4.91
111 (YI) China $0.084B 0.00
SHL Telemedicine (SHLT) Israel $0.077B 0.00
Future Health ESG (FHLT) United States $0.070B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Movano (MOVE) United States $0.027B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00